Acer Therapeutics Inc.

NASDAQ:ACER

0.6601 (USD) • At close November 20, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Revenue 01.26000.432-0.2462.9052.5561.2721.267000000.0460.046000.0040.0160.250.8162.902
Cost of Revenue 0000000000000000000000.2660.6882.539
Gross Profit 01.26000.432-0.2462.9052.5561.2721.267000000.0460.046000.0040.016-0.0160.1290.363
Gross Profit Ratio 010011111100000110011-0.0660.1580.125
Reseach & Development Expenses 11.9256.50811.84813.85112.4528.7256.49810.03912.1199.1816.3183.342.5852.1088.38913.0727.6139.8920.63300000
General & Administrative Expenses 12.68910.710.95516.0469.2615.2233.1224.2583.8333.6712.50902.2162.021005.4610000000
Selling & Marketing Expenses 000000000000000000000000
SG&A 12.68910.710.95516.0469.2615.2233.1224.2583.8333.6712.5092.4062.2162.0213.3413.4185.4610.553.1270.120.130.5280.9760.686
Other Expenses 0000000.0110.0690.0020.0380.3040.220.1690.2170.2370.2461.8211.758000000
Operating Expenses 24.61417.20822.80329.89721.71313.9489.85814.64916.3413.1879.1315.9664.974.34511.96716.73614.89512.23.760.1220.160.5280.9760.73
Operating Income -24.614-15.948-22.803-29.897-21.713-13.948-7.992-12.094-15.068-11.923-9.134-5.965-4.97-4.345-11.967-16.736-14.895-12.2-3.76-0.118-0.144-0.545-0.847-0.367
Operating Income Ratio 0-12.65700-50.24856.63-2.751-4.731-11.847-9.41300000-360.308-320.67100-30.121-8.987-2.183-1.038-0.127
Total Other Income Expenses Net -1.6230.574-0.083-1.0210.433-0.246-1.280.0750.016-4.7330.203-0.003-0.4992.9110.1152.680.839-7.214-0.8610.085-0.0180.002-00.203
Income Before Tax -26.237-15.374-22.885-29.418-21.281-14.194-7.98-12.019-15.052-16.656-8.931-5.968-5.469-1.434-11.852-14.667-14.056-19.414-4.621-0.033-0.162-0.542-0.847-0.164
Income Before Tax Ratio 0-12.20200-49.24857.63-2.747-4.702-11.835-13.1500000-315.767-302.61400-8.309-10.096-2.173-1.038-0.057
Income Tax Expense 1.623-0.6450.012-0.538-0.4320.2461.038-0.0050.0042.305-0.2035.9685.4691.43411.85214.66714.05619.4144.621-0.030.0550.0530.034-0.189
Net Income -27.86-14.729-22.897-28.88-21.281-14.194-7.98-12.019-15.052-16.656-8.931-5.968-5.469-1.434-11.852-14.667-14.056-19.414-4.621-0.088-0.199-0.598-0.881-0.178
Net Income Ratio 0-11.68900-49.24857.63-2.747-4.702-11.835-13.1500000-315.767-302.61400-22.372-12.408-2.395-1.079-0.061
EPS -1.77-1.03-2.06-2.86-2.49-3.84-11.72-21.26-39.65-91.56-113.13-77.65-93.91-33.48-329.28-642.07-764.35-363.69-2,147.15-385.85-4,857.44-13,900.98-18,348.92-3,792.51
EPS Diluted -1.77-1.03-2.06-2.86-2.49-3.84-11.72-21.26-39.65-91.56-113.13-77.65-93.91-33.48-329.28-642.07-764.35-363.69-2,147.15-385.85-4,857.44-13,900.98-18,348.92-3,792.51
EBITDA -24.548-15.877-22.732-28.339-21.252-13.945-6.696-2.568-14.663-11.532-8.827-5.756-4.801-7.318-11.765-18.098-13.225-4.954-2.744-0.202-0.113-0.532-0.827-0.551
EBITDA Ratio 0-12.70100-49.29356.569-1.954-4.593-11.528-9.10500000-389.615-284.72400-51.553-7.071-2.131-1.014-0.19